Position in REPL
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$906,341
-$463,294 QoQ
Shares Held
118,476
-15.9% QoQ
Ownership
0.141%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REPL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Rafferty Asset Management, LLC holds $408,627,656 across 136 Biotechnology names. REPL ranks #107 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
54,572 | $24,368,580 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
29,589 | $22,861,644 | |
| 3 | INSM |
INSMED Inc
|
116,069 | $18,979,602 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
50,553 | $16,726,471 | |
| 5 | APLS |
Apellis Pharmaceuticals, Inc.
|
180,471 | $7,260,348 | |
| 6 | MRNA |
Moderna, Inc.
|
114,194 | $5,801,055 | |
| 7 | INCY |
Incyte Corp
|
60,565 | $5,700,377 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
10,452 | $5,471,308 |
All Filings in REPL
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $906,341 | 118,476 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,369,635 | 140,909 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $455,000 | 108,592 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $738,842 | 79,531 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $766,428 | 78,608 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $936,199 | 77,308 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,109,305 | 101,214 | Shares | Sole | 2024-11-13 | |
| 2024-03-31 | $5,245,777 | 642,078 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $3,906,436 | 463,397 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $3,196,165 | 186,801 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $3,359,748 | 144,692 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $3,826,551 | 216,679 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $2,037,008 | 74,890 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,280,518 | 74,147 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $994,332 | 56,884 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $1,705,318 | 100,431 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $1,853,341 | 68,389 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $1,848,706 | 62,372 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $2,628,965 | 68,427 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $2,990,956 | 98,032 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $646,604 | 16,949 | Shares | Sole | 2021-02-10 | |
| No filing history on record for this holder in this stock. | ||||||